← Oncology Approval Tracker

FDA DECISION ·

Opdivo + platinum-doublet chemotherapy

nivolumab plus platinum-doublet chemotherapy · Bristol Myers Squibb

FDA approvalNew or expanded indicationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with resectable NSCLC and tumors at least 4 cm or with nodal involvement, receiving nivolumab plus a platinum doublet before surgery.

LAMPGEN ANALYSIS

Why it matters

This moves checkpoint blockade into the preoperative treatment window for selected resectable disease.

What research teams should watch

Track staging, therapy dates and the surgical handoff so treatment does not obscure operability or planned resection.

PRIMARY RECORDS

Sources